CardioCovidV1, Main, Corpus, bibRecord, 000074

COVID-19 and arterial hypertension: Hypothesis or evidence?

Identifieur interne : 000074 ( Main/Corpus ); précédent : 000073; suivant : 000075

COVID-19 and arterial hypertension: Hypothesis or evidence?

Auteurs : Marijana Tadic ; Cesare Cuspidi ; Guido Grassi ; Giuseppe Mancia

Source :

Journal of clinical hypertension (Greenwich, Conn.) [ 1751-7176 ] ; 2020.

RBID : pubmed:32627330

Abstract

Investigations reported that hypertension, diabetes, and cardiovascular diseases were the most prevalent comorbidities among the patients with coronavirus disease 2019 (COVID-19). Hypertension appeared consistently as the most prevalent risk factors in COVID-19 patients. Some investigations speculated about the association between renin-angiotensin-aldosterone system (RAAS) and susceptibility to COVID-19, as well as the relationship between RAAS inhibitors and increased mortality in these patients. This raised concern about the potential association between hypertension (and its treatment) and propensity for COVID-19. There are only a few follow-up studies that investigated the impact of comorbidities on outcome in these patients with conflicting findings. Hypertension has been proven to be more prevalent in patients with an adverse outcome (admission in intensive care unit, use of mechanical ventilation, or death). So far, there is no study that demonstrated independent predictive value of hypertension on mortality in COVID-19 patients. There are many speculations about this coronavirus and its relation with different risk factors and underlying diseases. The aim of this review was to summarize the current knowledge about the relationship between hypertension and COVID-19 and the role of hypertension on outcome in these patients.

DOI: 10.1111/jch.13925
PubMed: 32627330
PubMed Central: PMC7362072

Links to Exploration step

pubmed:32627330

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 and arterial hypertension: Hypothesis or evidence?</title>
<author><name sortKey="Tadic, Marijana" sort="Tadic, Marijana" uniqKey="Tadic M" first="Marijana" last="Tadic">Marijana Tadic</name>
<affiliation><nlm:affiliation>Department of Cardiology, University Hospital "Dr. Dragisa Misovic-Dedinje", Belgrade, Serbia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cuspidi, Cesare" sort="Cuspidi, Cesare" uniqKey="Cuspidi C" first="Cesare" last="Cuspidi">Cesare Cuspidi</name>
<affiliation><nlm:affiliation>University of Milan-Bicocca, Milan, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Clinical Research Unit, Istituto Auxologico Italiano, Meda, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grassi, Guido" sort="Grassi, Guido" uniqKey="Grassi G" first="Guido" last="Grassi">Guido Grassi</name>
<affiliation><nlm:affiliation>University of Milan-Bicocca, Milan, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name>
<affiliation><nlm:affiliation>University of Milan-Bicocca, Milan, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Policlinico di Monza, Monza, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32627330</idno>
<idno type="pmid">32627330</idno>
<idno type="doi">10.1111/jch.13925</idno>
<idno type="pmc">PMC7362072</idno>
<idno type="wicri:Area/Main/Corpus">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000074</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 and arterial hypertension: Hypothesis or evidence?</title>
<author><name sortKey="Tadic, Marijana" sort="Tadic, Marijana" uniqKey="Tadic M" first="Marijana" last="Tadic">Marijana Tadic</name>
<affiliation><nlm:affiliation>Department of Cardiology, University Hospital "Dr. Dragisa Misovic-Dedinje", Belgrade, Serbia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cuspidi, Cesare" sort="Cuspidi, Cesare" uniqKey="Cuspidi C" first="Cesare" last="Cuspidi">Cesare Cuspidi</name>
<affiliation><nlm:affiliation>University of Milan-Bicocca, Milan, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Clinical Research Unit, Istituto Auxologico Italiano, Meda, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grassi, Guido" sort="Grassi, Guido" uniqKey="Grassi G" first="Guido" last="Grassi">Guido Grassi</name>
<affiliation><nlm:affiliation>University of Milan-Bicocca, Milan, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name>
<affiliation><nlm:affiliation>University of Milan-Bicocca, Milan, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Policlinico di Monza, Monza, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of clinical hypertension (Greenwich, Conn.)</title>
<idno type="eISSN">1751-7176</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Investigations reported that hypertension, diabetes, and cardiovascular diseases were the most prevalent comorbidities among the patients with coronavirus disease 2019 (COVID-19). Hypertension appeared consistently as the most prevalent risk factors in COVID-19 patients. Some investigations speculated about the association between renin-angiotensin-aldosterone system (RAAS) and susceptibility to COVID-19, as well as the relationship between RAAS inhibitors and increased mortality in these patients. This raised concern about the potential association between hypertension (and its treatment) and propensity for COVID-19. There are only a few follow-up studies that investigated the impact of comorbidities on outcome in these patients with conflicting findings. Hypertension has been proven to be more prevalent in patients with an adverse outcome (admission in intensive care unit, use of mechanical ventilation, or death). So far, there is no study that demonstrated independent predictive value of hypertension on mortality in COVID-19 patients. There are many speculations about this coronavirus and its relation with different risk factors and underlying diseases. The aim of this review was to summarize the current knowledge about the relationship between hypertension and COVID-19 and the role of hypertension on outcome in these patients.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32627330</PMID>
<DateRevised><Year>2020</Year>
<Month>07</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-7176</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Jul</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Journal of clinical hypertension (Greenwich, Conn.)</Title>
<ISOAbbreviation>J Clin Hypertens (Greenwich)</ISOAbbreviation>
</Journal>
<ArticleTitle>COVID-19 and arterial hypertension: Hypothesis or evidence?</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/jch.13925</ELocationID>
<Abstract><AbstractText>Investigations reported that hypertension, diabetes, and cardiovascular diseases were the most prevalent comorbidities among the patients with coronavirus disease 2019 (COVID-19). Hypertension appeared consistently as the most prevalent risk factors in COVID-19 patients. Some investigations speculated about the association between renin-angiotensin-aldosterone system (RAAS) and susceptibility to COVID-19, as well as the relationship between RAAS inhibitors and increased mortality in these patients. This raised concern about the potential association between hypertension (and its treatment) and propensity for COVID-19. There are only a few follow-up studies that investigated the impact of comorbidities on outcome in these patients with conflicting findings. Hypertension has been proven to be more prevalent in patients with an adverse outcome (admission in intensive care unit, use of mechanical ventilation, or death). So far, there is no study that demonstrated independent predictive value of hypertension on mortality in COVID-19 patients. There are many speculations about this coronavirus and its relation with different risk factors and underlying diseases. The aim of this review was to summarize the current knowledge about the relationship between hypertension and COVID-19 and the role of hypertension on outcome in these patients.</AbstractText>
<CopyrightInformation>© 2020 Wiley Periodicals LLC.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tadic</LastName>
<ForeName>Marijana</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-6235-5152</Identifier>
<AffiliationInfo><Affiliation>Department of Cardiology, University Hospital "Dr. Dragisa Misovic-Dedinje", Belgrade, Serbia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cuspidi</LastName>
<ForeName>Cesare</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>University of Milan-Bicocca, Milan, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Clinical Research Unit, Istituto Auxologico Italiano, Meda, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grassi</LastName>
<ForeName>Guido</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>University of Milan-Bicocca, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mancia</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>University of Milan-Bicocca, Milan, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Policlinico di Monza, Monza, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Clin Hypertens (Greenwich)</MedlineTA>
<NlmUniqueID>100888554</NlmUniqueID>
<ISSNLinking>1524-6175</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular disease</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">outcome</Keyword>
<Keyword MajorTopicYN="N">risk factors</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>05</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32627330</ArticleId>
<ArticleId IdType="doi">10.1111/jch.13925</ArticleId>
<ArticleId IdType="pmc">PMC7362072</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circulation. 2018 May 29;137(22):2344-2356</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29449338</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1084-H1090</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32228252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2016 Aug;49:129-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27352628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2003 Aug;58(8):686-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12885985</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2020 May 14;55(5):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32217650</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32209890</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2017 Dec 9;390(10112):2549-2558</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29102084</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2441-2448</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32356628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>High Blood Press Cardiovasc Prev. 2020 Apr;27(2):105-108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32266708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Nephrol. 2020 Jun;16(6):305-307</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32246101</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):757-760</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32228222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Res Cardiol. 2020 May;109(5):531-538</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32161990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32155444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Acad Emerg Med. 2020 Mar 24;8(1):e35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32232218</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2431-2440</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32356627</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Feb 28;368:m810</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32111649</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hypertens. 2020 May;38(5):781-782</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32195824</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circ Res. 2020 Jun 5;126(12):1671-1681</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302265</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32242738</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000074 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000074 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CardioCovidV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32627330
   |texte=   COVID-19 and arterial hypertension: Hypothesis or evidence?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32627330" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CardioCovidV1

This area was generated with Dilib version V0.6.35.
Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021

	Serveur d'exploration Covid et maladies cardiovasculaires
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Covid et maladies cardiovasculaires

COVID-19 and arterial hypertension: Hypothesis or evidence?

COVID-19 and arterial hypertension: Hypothesis or evidence?

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki